Collaborative efforts between healthcare stakeholders are key to improvements in patient outcomes, quality of care and patient experience. We see this in play in our Greater China market, with IHH China and Gleneagles Hospital Hong Kong embarking on new partnerships. The latter also signed a strategic cooperation agreement with China-based healthcare organisation Jiahui Health to deliver a range of healthcare services.
On 10 and 11 August, a team from Gleneagles Hospital Hong Kong led by its CEO Dr Kenneth Tsang, made a special visit to Shanghai to explore new collaborations with IHH China.
During their tour of Parkway Shanghai Hospital, Parkway Gleneagles Medical & Surgical Center, Parkway Hospital People’s Square and other medical centers, the parties engaged in in-depth discussions, diving into the unique features of our China clinical services, current operations, and recent development plans.
Plans are set in motion to explore academic conferences, multi-site physician practices, seamless patient referrals, second opinions, and the usage of FDA-approved drugs and devices between IHH China and Gleneagles Hospital Hong Kong. Indeed, the future looks brighter as our business units join hands to drive success and advancements in healthcare together.
Separately, Gleneagles Hospital Hong Kong and Jiahui Health sealed a strategic cooperation agreement on 21 August in Shenzhen, reaffirming their dedication to delivering exceptional healthcare services.
Under the game-changing partnership, Gleneagles Hospital Hong Kong and Jiahui Health will harness their collective expertise to advance healthcare via a wide range of services. These include teleconsultations, seamless patient referrals, cross-region consultations, medical exchange and training, precise diagnosis and treatment, and streamlined drug application processes.
Related Stories
Harnessing AI to Advance Patient-Centred Healthcare
Artificial intelligence is rapidly transforming healthcare, creating new opportunities to enhance patient care, improve clinical efficiency and accelerate medical innovation.
Supporting Women's Health Through Open Conversations
On 10 July, the Federation of Indian Chambers of Commerce & Industry Ladies Organisation (FICCI FLO), in partnership with Fortis Healthcare, hosted Menopause 360°: Body, Mind and Hormones, an initiative dedicated to raising awareness and encouraging open conversations around menopause.
IHH Laboratories D.N.A. Award
Discovery. Nurturing. Accuracy. The IHH Labs D.N.A. Award returns in 2026 to recognise medical technologists whose work forms a vital part of quality patient care.
.jpg?sfvrsn=21d67f46_1)
IHH Singapore Collaborates with Insurers to Improve Affordability of Private Hospital Care
People-led Innovation Driving Impact Across IHH Healthcare
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
